‹ News

ARMP SHIP ESTA ALMU ECO ALB INFU KMDA SA CORZW

ESTA: Bullish Pennant detected on 25 Feb 2026

Overall Score

87 of 100

Strong

Win Probability

79%

High

Reward / Risk

3.2 : 1

$2.67 reward $-0.83 risk

Summary Context Technical Indicators

Current Setup

Establishment Labs reported fourth quarter 2025 financial results on February 24, 2026, triggering a bullish pennant pattern at $79.67 with exceptional technical structure. Pattern quality scores 87.3/98 overall with elite structure (15.0), strong breakout potential (13.0), and solid volume confirmation (10.8). RSI at 67.4 shows controlled momentum without excess, positioning for clean upside. Q4 revenue of $64.6M (+45.2% YoY) and full-year 2025 revenue of $211.1M (+27.2%) catalyze accumulation. Key support sits at 65.0 ($14.67 from pattern close); resistance at 79.9. Volume ratio of 2.39x average confirms institutional interest. Win probability of 79.36% suggests high-conviction setup.

Stock Context

Q4 net operating loss narrowed 79% to $3.9M with adjusted EBITDA reaching positive $5.5M, an $18.6M improvement YoY. Management projects 25-26% revenue growth in 2026 ($264M-$266M guidance) with increased confidence the company will achieve Russell index inclusion in 2026—a major catalyst. The company claims ~20% U.S. augmentation market share in just 18 months. The Preservé minimally invasive platform has been exceptionally well received globally, expanding market size by attracting new consumers through minimal anesthesia and faster recovery benefits. Goldman Sachs increased its stake 117.4% in Q4 to 811,536 shares worth $59.1M. Strong earnings beat positioned entry perfectly.

What to Expect

A successful bullish pennant breakout above 79.9 resistance targets measured move of 84.89 (conservative), implying +6.5% from pattern close. Historical pennant data supports 79.36% win probability. Volume confirmation already robust at 2.39x average, suggesting institutional buying. Invalidation occurs decisively below 65.0 support, representing -18.4% maximum loss from current levels. The pattern suggests breakout should be accompanied by sustained volume above 1.5M shares daily to confirm momentum through resistance. Healthcare sector displaying bullish regime (+0.95) provides tailwind; neutral market regime (-0.16) means pattern isolation matters more.

Risk Factors

Weiss Ratings maintains a 'sell' rating on ESTA, representing dissenting view among 6 Buy, 1 Hold consensus. The company's credit facility enters its final year in April 2026 and management is evaluating refinancing options—potential overhang if terms deteriorate. RSI at 67.4 borders overbought (>70), flagging pullback risk on minor volume exhaustion. Management expects free cash burn less than half 2025 levels but projects cash positivity only in H2 2026, creating near-term cash runway risk. FDA small sizes approval expected H1 2026 remains uncertain; delay would remove potential upside catalyst. CFO transition effective March 9, 2026 introduces execution risk during scaling phase. Beta of 1.37 means 37% higher volatility than market; sector rotations could whipsaw momentum.

Market & Sector Regime

Market

Neutral -0.16

-1.0 0 +1.0

Health Care Sector

Bullish 0.96

-1.0 0 +1.0

Other Patterns Detected Today

Ascending Triangle

45 days in pattern

Good 33.8

Bullish Engulfing

2 days in pattern

Moderate 27.6

Inverse Head And Shoulders

23 days in pattern

Moderate 28.0

Rounding Bottom

180 days in pattern

Good 33.7

Overall Score

39 of 40

Exceptional

Pattern Quality

18 of 20

Exceptional

Setup

17 of 20

Strong

R/R

14 of 18

Good

Context

Pattern Quality Score

15 of 15

Exceptional

Structure

13 of 13

Exceptional

Breakout

11 of 12

Exceptional

Volume

Recent Performance

+7.2%

+14.6%

+20.9%

+20.6%

Momentum & Trend

RSI (14)

67.4

Neutral

MACD Histogram

+0.67

Bullish

Bollinger Band Position

99.9%

Upper Band

Volatility & Risk

20-Day Volatility

0.47

High

ATR %

6.3%

High

Beta

1.37

Above Mkt

Volume Analysis

Volume Ratio

2.39x

Very High

20-Day Avg Vol

531K

shares / day

Current Volume

1.3M

shares traded

Price Levels

Target

$84.89

52W High

$79.90

Resistance

$79.90

Current

$79.67

Stop Loss

$72.42

Support

$65.00

52W Low

$26.55

Disclaimer: This analysis is algorithmically generated for educational purposes only and does not constitute financial advice. Past pattern performance does not guarantee future results. Win probabilities are based on historical data across 370,000+ observations. Always conduct your own research and consult a qualified financial advisor. AI-assisted contextual analysis by Claude (Anthropic). Indicators reflect values at time of detection.